Axel Ducret

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

Pharmaceutics

Journal of proteome research

Clinical chemistry

PloS one

This page only lists publications with an associated author ORCID identifier.

Publications

Tatjana Sela, Mads Mansø, Michel Siegel, Céline Marban-Doran, Axel Ducret, Jens Niewöhner, Jacob Ravn, Rainer E Martin, Annika Sommer, Sabine Lohmann, Ben-Fillippo Krippendorff, Mette Ladefoged, Annette Indlekofer, Tom Quaiser, Florian Bueddefeld, Erich Koller, Mohamed Y Mohamed, Tobias Oelschlaegel, Kurt Vesterager Gothelf, Kerstin Hofer, Felix F Schumacher
Diligent Design Enables Antibody-ASO Conjugates with Optimal Pharmacokinetic Properties. Bioconjugate chemistry (2023)
Daisy Unsihuay, William S Phipps, Amanda G Paulovich, Jessica R Chapman, Axel Ducret, Livia S Eberlin, Jeffrey M Spraggins, Richard J A Goodwin
Tissue Mass Spectrometry: How Solid Is Our Future? Clinical chemistry (2023)
Katharina Hartman, Guido Steiner, Michel Siegel, Cary M Looney, Timothy P Hickling, Katharine Bray-French, Sebastian Springer, Céline Marban-Doran, Axel Ducret
Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes. Biology 12 (9) (2023)
Michel Siegel, Guido Steiner, Linnea C Franssen, Francesca Carratu, James Herron, Katharina Hartman, Cary M Looney, Axel Ducret, Katharine Bray-French, Olivier Rohr, Timothy P Hickling, Noel Smith, Céline Marban-Doran
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics. Pharmaceutics 14 (12) (2022)
Michel Siegel, Guido Steiner, Linnea C Franssen, Francesca Carratu, James Herron, Katharina Hartman, Cary M Looney, Axel Ducret, Katharine Bray-French, Olivier Rohr, Timothy P Hickling, Noel Smith, Céline Marban-Doran
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics. Pharmaceutics 14 (12) (2022)
Michel Siegel, Guido Steiner, Linnea C Franssen, Francesca Carratu, James Herron, Katharina Hartman, Cary M Looney, Axel Ducret, Katharine Bray-French, Olivier Rohr, Timothy P Hickling, Noel Smith, Céline Marban-Doran
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics. Pharmaceutics 14 (12) (2022)
Christian Augsberger, Gerulf Hänel, Wei Xu, Vesna Pulko, Lydia Jasmin Hanisch, Angelique Augustin, John Challier, Katharina Hunt, Binje Vick, Pier Edoardo Rovatti, Christina Krupka, Maurine Rothe, Anne Schönle, Johannes Sam, Emmanuelle Lezan, Axel Ducret, Daniela Ortiz Franyuti, Antje-Christine Walz, Jörg Benz, Alexander Bujotzek, Felix S Lichtenegger, Christian Gassner, Alejandro Carpy, Victor Lyamichev, Jigar Patel, Nikola P Konstandin, Antje Tunger, Marc Schmitz, Michael von Bergwelt-Baildon, Karsten Spiekermann, Luca Vago, Irmela Jeremias, Estelle Marrer-Berger, Pablo Umaña, Christian Klein, Marion Subklewe
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC specific T-cell bispecific antibody. Blood (2021)
Vittoria Massafra, Sofia Tundo, Aline Dietzig, Axel Ducret, Christian Jost, Christiane Neumann, Roland E Kontermann, Hendrik Knoetgen, Martin Steegmaier, Andrea Romagnani, Yvonne A Nagel
Proteolysis-Targeting Chimeras Enhance T Cell Bispecific Antibody-Driven T Cell Activation and Effector Function through Increased MHC Class I Antigen Presentation in Cancer Cells. Journal of immunology (Baltimore, Md. : 1950) 207 (2) (2021)
Guido Steiner, Céline Marban-Doran, Jessica Langer, Tatiana Pimenova, Gonzalo Duran-Pacheco, Denise Sauter, Anja Langenkamp, Corinne Solier, Thomas Singer, Katharine Bray-French, Axel Ducret
Correction to "Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity". Journal of proteome research 20 (1) (2020)
Guido Steiner, Céline Marban-Doran, Jessica Langer, Tatiana Pimenova, Gonzalo Duran-Pacheco, Denise Sauter, Anja Langenkamp, Corinne Solier, Thomas Singer, Katharine Bray-French, Axel Ducret
Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity. Journal of proteome research 19 (9) (2020)
Axel Ducret, Ian James, Sabine Wilson, Martina Feilke, Andreas Tebbe, Nikolaj Dybowski, Sarah Elschenbroich, Martin Klammer, Adele Blackler, Wei-Li Liao, Yuan Tian, Thomas Friess, Birgit Bossenmaier, Gabriele Dietmann, Christoph Schaab, Todd Hembrough, Maurizio Ceppi
Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial. PloS one 14 (3) (2019)

Axel Ducret.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Axel Ducret